Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Resveratrol Drug Study Halted - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Resveratrol Drug Study Halted

Sirtris Pharmaceuticals, a subsidiary of GlaxoSmithKline, has halted a clinical trial evaluating a resveratrol-based drug after some patients suffered kidney damage.

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Sirtris Pharmaceuticals, a subsidiary of GlaxoSmithKline, has halted a clinical trial evaluating a resveratrol-based drug after some patients suffered kidney damage.

The phase 2 study was designed to evaluate the use of resveratrol as a stand alone treatment for multiple myeloma, as well as in conjunction with a cancer drug. Five of the 24 patients involved in the study developed kidney problems.

The trial had been expected to run until December and involve up to 61 patients.

The same drug, SRT501, was previously evaluated in three completed clinical trials in relation to type 2 diabetes.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters